nad and glp 1 together EllieMD | Exploring the Effects
Description
It contains no added sugars and uses stevia instead for gentle sweetness

Another important consideration when evaluating the impact of these medications on bone health outcomes is the sustainability of GLP1Ra use as weight regain following cessation of treatment is expected (Quarenghi et al., 2025)
Due to tirzepatide's pharmacokinetic profile (peak concentration at approximately 24-48 hours and half-life of about 5 days), symptoms may persist for several days following a double dose, with effects potentially lasting longer than with shorter-acting GLP-1 receptor agonists
Supports Appetite Control with GLP-1 Activation Formulated to help you stay on track by managing hunger and promoting a feeling of fullness.

9-11 If a GLP-1 RA is determined to be the best option for the patient, pharmacists and providers should consider the following recommendations: Follow dosing recommendations as directed by the manufacturer
